bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.07.28.667278

Scalable automated segmentation quantifies mitochondrial proteins and morphology at the nanoscale

Abstract

Ultrastructural changes of mitochondria are closely associated with metabolic dysfunction, leading to a variety of human disorders. These changes can be visualized by pan-Expansion Microscopy (pan-ExM), a 3D microscopy technique requiring only standard fluorescence microscopes, at a throughput exceeding that of the current gold standard, 3D electron microscopy, by orders of magnitude. However, a lack of tools that enable the characterization and quantification of the observed ultrastructural features in the acquired 3D datasets at a comparable throughput has hindered the widespread adoption of pan-ExM for quantitative imaging. Here, we present an automated deep-learning based segmentation approach that utilizes pan-ExMs power to acquire multi-channel images and uses specific labeling as the annotation for the training of the segmentation network. This molecular annotation reduces the required manual annotation effort for mitochondria substructures to just a few hours when setting up the experiment and thereby provides access to 3D suborganellar morphology of mitochondria at an unprecedented throughput. Our approach, which we term MAPS (Mitochondrial Automated Pan-ExM Segmentation), enables for the first time to quantify mitochondrial ultrastructural morphology at scale. We demonstrate this power by characterizing the 3D mitochondrial morphology at the organelle and sub-organelle level in tens of HeLa cells under different treatments and localizing mitochondrial proteins in the sub-organellar context. To demonstrate our technology in tissue, we compare the ultrastructural morphology of mitochondria in proximal tubules of kidneys of mice exhibiting acute kidney injury (AKI) with those of untreated mice, revealing striking differences in their cristae structure. MAPS can easily be adapted to different cell and tissue types, allowing the analysis of tens of samples per day, and therefore provides a versatile tool for a comprehensive understanding of mitochondrial ultrastructural changes in many disease contexts. Requiring only standard fluorescence microscopes and computer infrastructure, MAPS is readily adoptable by any lab. HighlightsO_LIMAPS utilizes specific labeling to train a segmentation model for 3D super-resolution pan-ExM images C_LIO_LISuborganellar mitochondrial features and their changes in disease models are quantified at high throughput C_LIO_LI3D protein distributions are correlated to ultrastructural features in mitochondria C_LIO_LIRequiring only standard lab infrastructure, MAPS is readily adoptable C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tian, Y., Sauer, A., Dmitrieva, M., Han, H., Mekbib, H. T., Bao, Y., Guo, X., Chen, T.-m., Safirstein, R., Desir, G., Rittscher, J., Bewersdorf, J.. 2025-07-30. Scalable automated segmentation quantifies mitochondrial proteins and morphology at the nanoscale. https://doi.org/10.1101/2025.07.28.667278

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗

Matrix Gla Protein deficiency reveals a previously unrecognized mucosal calcification in the mouse airways

Tracheal calcification is a common finding that is considered to have limited clinical significance when detected most often in elderly individuals. Despite its frequent occurrence, the cellular and molecular mechanisms at the origin of tracheal calcification remain largely unexplored. In this context, we aimed to characterize the development of tracheal calcification, and to determine the role of matrix Gla protein (MGP), a major inhibitor of ectopic calcification whose genetic or pharmacologic deficiency is associated with premature tracheal calcification in humans. We found that wild-type mice undergo an unexpected early physiologic calcification of the tracheal cartilage rings beginning around one month after birth. This calcification progresses in a dynamic rostro-caudal sequence through a process involving terminal differentiation of tracheal chondrocytes. These findings challenge the prevailing view that tracheal cartilage is a permanent hyaline cartilage and instead reveals an early and highly organized physiologic calcification process. Furthermore, our findings further identify MGP as a key regulator of calcification within the respiratory tract. Indeed, MGP deficiency not only markedly accelerates tracheal cartilage calcification through a similar pattern and mechanism but also induces a previously unrecognized calcification of the tracheal mucosa, a lesion absent in wild-type mice. These alterations could partly explain the respiratory manifestations observed in MGP-deficient patients having Keutel syndrome, which include dyspnea, cough, stridor, and recurrent infections, symptoms previously being mainly attributed to calcification of the tracheal cartilage rings.

cell biology↗